The role of JAK/STAT signaling pathway and its inhibitors in diseases

被引:698
作者
Xin, Ping [1 ]
Xu, Xiaoyun [1 ]
Deng, Chengjie [1 ]
Liu, Shuang [1 ]
Wang, Youzhi [2 ]
Zhou, Xuegang [1 ]
Ma, Hongxing [3 ]
Wei, Donghua [1 ]
Sun, Shiqin [1 ]
机构
[1] Harbin Med Univ Daqing, Coll Pharm, Daqing 163319, Peoples R China
[2] China Pharmaceut Univ, Sch Pharm, Dept Med Chem, Nanjing 210009, Peoples R China
[3] Southeast Univ, Clin Lab Dept, Najing Lishui Peoples Hosp, Zhongda Hosp Lishui Branch, Nanjing 211200, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
JAK/STAT signaling pathway; Negative regulators; JAK/STAT pathway and diseases; JAKs inhibitors and diseases; JANUS KINASE INHIBITOR; FIBROBLAST-LIKE SYNOVIOCYTES; JAK-STAT PATHWAY; ADJUVANT-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; TRANSCRIPTION FACTORS; INADEQUATE RESPONSE; PHASE IIB; SOCS-BOX;
D O I
10.1016/j.intimp.2020.106210
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The JAK/STAT signaling pathway is an universally expressed intracellular signal transduction pathway and involved in many crucial biological processes, including cell proliferation, differentiation, apoptosis, and immune regulation. It provides a direct mechanism for extracellular factors-regulated gene expression. Current researches on this pathway have been focusing on the inflammatory and neoplastic diseases and related drug. The mechanism of JAK/STAT signaling is relatively simple. However, the biological consequences of the pathway are complicated due to its crosstalk with other signaling pathways. In addition, there is increasing evidence indicates that the persistent activation of JAK/STAT signaling pathway is closely related to many immune and inflammatory diseases, yet the specific mechanism remains unclear. Therefore, it is necessary to study the detailed mechanisms of JAK/STAT signaling in disease formation to provide critical reference for clinical treatments of the diseases. In this review, we focus on the structure of JAKs and STATs, the JAK/STAT signaling pathway and its negative regulators, the associated diseases, and the JAK inhibitors for the clinical therapy.
引用
收藏
页数:11
相关论文
共 179 条
[1]  
Abroun S, 2015, CELL J, V17, P395
[2]   Therapeutic targets for rheumatoid arthritis: Progress and promises [J].
Alghasham, Abdullah ;
Rasheed, Zafar .
AUTOIMMUNITY, 2014, 47 (02) :77-94
[3]   Protein tyrosine phosphatases in the human genome [J].
Alonso, A ;
Sasin, J ;
Bottini, N ;
Friedberg, I ;
Friedberg, I ;
Osterman, A ;
Godzik, A ;
Hunter, T ;
Dixon, J ;
Mustelin, T .
CELL, 2004, 117 (06) :699-711
[4]  
[Anonymous], J NEONATAL NURS
[5]  
[Anonymous], SCI REP
[6]  
[Anonymous], PHARM RES
[7]  
[Anonymous], P ROY SOC MED
[8]  
[Anonymous], INT J HEMATOL ONCOL
[9]  
[Anonymous], GENOMICS
[10]  
[Anonymous], EXP REV CLIN IMMUNOL